Marshall LA - Search Results

1

An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.

Jackson JR, Gilmartin A, Imburgia C, Winkler JD, Marshall LA, Roshak A. Jackson JR, et al. Among authors: marshall la. Cancer Res. 2000 Feb 1;60(3):566-72. Cancer Res. 2000. PMID: 10676638

2

Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation.

Marshall LA, Bolognese B, Winkler JD, Roshak A. Marshall LA, et al. J Biol Chem. 1997 Jan 10;272(2):759-65. doi: 10.1074/jbc.272.2.759. J Biol Chem. 1997. PMID: 8995361 Free article.

3

Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.

Winkler JD, Bolognese BJ, Roshak AK, Sung CM, Marshall LA. Winkler JD, et al. Among authors: marshall la. Biochim Biophys Acta. 1997 Jun 2;1346(2):173-84. doi: 10.1016/s0005-2760(97)00032-5. Biochim Biophys Acta. 1997. PMID: 9219900

4

Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells.

Anderson KM, Roshak A, Winkler JD, McCord M, Marshall LA. Anderson KM, et al. Among authors: marshall la. J Biol Chem. 1997 Nov 28;272(48):30504-11. doi: 10.1074/jbc.272.48.30504. J Biol Chem. 1997. PMID: 9374544 Free article.

5

Utility of oligonucleotides as tools to study the function and regulation of 85 kDa phospholipase A2.

Marshall LA, Roshak AK. Marshall LA, et al. Antisense Nucleic Acid Drug Dev. 1998 Apr;8(2):153-7. doi: 10.1089/oli.1.1998.8.153. Antisense Nucleic Acid Drug Dev. 1998. PMID: 9593056 Review. No abstract available.

6

The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase.

Roshak AK, Capper EA, Imburgia C, Fornwald J, Scott G, Marshall LA. Roshak AK, et al. Among authors: marshall la. Cell Signal. 2000 Jun;12(6):405-11. doi: 10.1016/s0898-6568(00)00080-2. Cell Signal. 2000. PMID: 11202906

7

SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.

Marshall LA, Hall RH, Winkler JD, Badger A, Bolognese B, Roshak A, Flamberg PL, Sung CM, Chabot-Fletcher M, Adams JL, et al. Marshall LA, et al. J Pharmacol Exp Ther. 1995 Sep;274(3):1254-62. J Pharmacol Exp Ther. 1995. PMID: 7562496

8

Characterization of phospholipase A2 release by elicited-peritoneal macrophage and its relationship to eicosanoid production.

Marshall LA, Bolognese B, Roshak A. Marshall LA, et al. J Lipid Mediat Cell Signal. 1994 Sep;10(3):295-313. J Lipid Mediat Cell Signal. 1994. PMID: 7812679

9

Suppression of monocyte 85-kDa phospholipase A2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis.

Roshak A, Sathe G, Marshall LA. Roshak A, et al. Among authors: marshall la. J Biol Chem. 1994 Oct 21;269(42):25999-6005. J Biol Chem. 1994. PMID: 7929310 Free article.

10

Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.

Marshall LA, Winkler JD, Griswold DE, Bolognese B, Roshak A, Sung CM, Webb EF, Jacobs R. Marshall LA, et al. J Pharmacol Exp Ther. 1994 Feb;268(2):709-17. J Pharmacol Exp Ther. 1994. PMID: 8113982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters